Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan

BACKGROUND: To assess persistence rates of biologic agents for the treatment of rheumatoid arthritis in Japan. METHODS: Based on Japanese claims data of 16,214 patients between 2012 and 2014, 6-, 12-, and 18-month persistence rates of different biologic agents were calculated. Determinants of persis...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahlich, Jörg, Sruamsiri, Rosarin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981174/
https://www.ncbi.nlm.nih.gov/pubmed/27540283
http://dx.doi.org/10.2147/PPA.S110147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981174/
https://www.ncbi.nlm.nih.gov/pubmed/27540283
http://dx.doi.org/10.2147/PPA.S110147

Ejemplares similares